Yeolyan Launches Brand New Website!
Yeolyan Hematology and Oncology Center, MOH of Armenia shared a proud post on LinkedIn:
”We combine experience and technology for you
We are pleased to inform that the new, rebranded, trilingual website of the Yeolyan Hematology and Oncology Center of the Ministry of Health of the Republic of Armenia is already available.
It was created taking into account modern requirements and standards.
In addition to information about the center’s services, activities, and specialists, you can find useful information and tips for maintaining your health.
We attach great importance to the patient-doctor connection, so through this platform you will have the opportunity to contact a specialist directly and register online for a visit (this opportunity will be fully available in the future).
Particular importance has also been given to blood donors: to reduce the waiting time for donors, as well as to avoid queues on site, a section for donor registration and preliminary completion of the questionnaire has been created.
Everything for your comfort and health. Yeolyan Center for Hematology and Oncology.”
Yeolyan Hematology and Oncology Center is a national centralized hospital for blood disorders, with extensively developed oncology units.
The hospital recently rebranded several of its divisions, including the Hemophilia Center, Transplantation Unit, Blood Bank, Adult Hematology and Oncology Centers, Pediatric Cancer and Blood Disorders Center (PCBDCA) and Palliative Care Center.
The center is also actively engaged in scientific research and clinical trials.
Find all the information on the newly launched official website.
Stay updated with Hemostasis Today.
-
Aug 13, 2025, 09:21VELORA Discover Study Now Enrolling: Advancing Care for Type 1 Von Willebrand Disease
-
Aug 13, 2025, 06:44Chokri Ben Lamine: Causes and Diagnostic Approach to PTT Prolongation
-
Aug 13, 2025, 05:41ISTH 2025 Recorded Sessions Now Available on ISTH Academy
-
Aug 13, 2025, 01:39Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
-
Aug 12, 2025, 20:03David McIntosh Urges WHO, the European Blood Alliance, the International Plasma and Fractionation Association to Stop Opposition to VRCD
-
Aug 13, 2025, 16:24Giuseppe Lippi on Laboratory Diagnostics for Immediate Management of Acute Bleeding
-
Aug 13, 2025, 06:13Pip Nicolson: Understanding VITT From COVID-19 Vaccines
-
Aug 13, 2025, 05:23Baseline Hemoglobin Predicts Outcomes in Acute VTE: Low Hb Linked to Higher Bleeding, Ischemia and Mortality Risk
-
Aug 13, 2025, 04:13Lindsey George on Gene Therapy Transforming Hemophilia Care
-
Aug 13, 2025, 02:26Case Report Alert: Basilar Artery Occlusion in IgA-APS
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025